Symbotic stock: SYM ends 2025 lower as New Year shuts markets — what investors watch next
2 January 2026
2 mins read

Symbotic stock: SYM ends 2025 lower as New Year shuts markets — what investors watch next

NEW YORK, January 1, 2026, 18:37 ET — Market closed

  • Symbotic shares last closed at $59.50 on Dec. 31, down 1.28%.
  • U.S. stock markets are closed for New Year’s Day; trading resumes Friday, Jan. 2.
  • Focus is shifting to early-February earnings expectations and progress with big customers.

Symbotic Inc shares finished the final U.S. trading session of 2025 in the red, with Wall Street closed on Thursday for the New Year’s Day holiday. Trading resumes on Friday. 1

The break in trading comes as investors reassess richly valued automation and robotics names after a late-year slide in broader equities. For Symbotic, small shifts in expectations around growth and execution have tended to show up quickly in the stock.

The next near-term test is the company’s next quarterly update, alongside early-January data that can move interest-rate expectations. Higher yields often pressure growth stocks because future profits are discounted more heavily.

Symbotic closed at $59.50 on Wednesday, down 1.28% on the day, a move that lagged a 0.74% decline in the S&P 500, Zacks Equity Research said. Zacks’ consensus forecast calls for revenue of about $622.3 million and earnings per share of $0.08 in the coming quarter. It also flagged a forward price-to-earnings ratio — a valuation measure based on forecast profit — of roughly 150. 2

Market data showed SYM traded between $59.40 and $61.00 in the session and was valued at roughly $7.1 billion.

Symbotic sells robots and software that automate large distribution centers, handling pallets and cases for major retailers and wholesalers, according to Reuters company information. In its latest annual filing, the company said Walmart accounted for about 85% of fiscal 2025 revenue and most of a $22.5 billion backlog — contracted work that has not yet been delivered. 3

In its most recent results, Symbotic reported fourth-quarter revenue of $618 million and a net loss of $19 million, and projected first-quarter revenue of $610 million to $630 million; it also guided adjusted EBITDA — earnings before interest, taxes, depreciation and amortization — to $49 million to $53 million. “We delivered on our commitments to achieve strong top-line growth,” CEO Rick Cohen said in the Nov. 24 release. 4

A December stock sale also left a mark on trading. A prospectus supplement showed Symbotic sold 6.5 million shares in a 10 million-share offering priced at $55 each, while a SoftBank-linked selling holder sold 3.5 million shares; the company estimated net proceeds of about $345 million for general corporate purposes. 5

TD Cowen raised its price target on Symbotic to $75 from $50 on Dec. 3 and maintained a Buy rating, Insider Monkey reported, citing customer expansion and faster deployment timelines while noting the valuation had become stretched after the latest earnings report. 6

Before Friday’s reopening, investors will watch the Institute for Supply Management’s manufacturing PMI report due at 10 a.m. ET, an early read on economic momentum that can move Treasury yields and rate bets. 7

The next major U.S. labour-market test is the December employment report scheduled for Jan. 9, the Bureau of Labor Statistics shows. Big swings in rates around the data can be amplified in high-multiple stocks. 8

Technically, traders are watching whether SYM can regain the $60 level and hold above the mid-$59 area that marked Wednesday’s low. A move back above $61 would put the prior day’s high back in play.

For longer-term bulls, the focus remains on execution: expanding beyond Walmart, ramping new verticals such as healthcare, and keeping deployments on schedule as customers transition to next-generation designs.

Stock Market Today

Healthcare stocks in focus: Molina shock, FDA “copycat” warning and XLV set up Monday’s trade

7 February 2026
New York, Feb 7, 2026, 13:23 EST — Market closed. Molina Healthcare shares tumbled on Friday after the Medicaid-focused insurer projected 2026 adjusted profit of at least $5 a share, well below Wall Street expectations, and said it would exit its Medicare Advantage Part D prescription drug plans in 2027. Molina closed down 25.5% at $131.72, while the Health Care Select Sector SPDR Fund (XLV) rose 1.8% to $157.71. CEO Joseph Zubretsky called 2026 a “trough year” for Medicaid margins, and Molina said its Part D business and a new Florida Medicaid contract cut the outlook by $1 and $1.50
Energy stocks set for a geopolitical week after Iran warning and oil rebound

Energy stocks set for a geopolitical week after Iran warning and oil rebound

7 February 2026
U.S. energy stocks rose Friday, with the S&P 500 energy sector up 1.88% and Exxon Mobil gaining 2.03%. Brent crude settled at $68.05 a barrel after Iran threatened U.S. bases if attacked. Saudi Aramco cut March Arab Light crude prices to a five-year low for Asia. Kazakhstan’s CPC Blend exports may drop 35% this month due to Tengiz oilfield disruptions.
Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

7 February 2026
U.S. financial stocks rose Friday, with the XLF fund up 1.8% and the Dow closing above 50,000 for the first time, gaining 2.47%. Goldman Sachs jumped 4.3%, JPMorgan 3.9%, and Citigroup 6.0%. The Federal Reserve held rates steady, and San Francisco Fed President Mary Daly signaled possible cuts this year. Investors await January jobs and inflation data next week.
Walmart stock today: WMT slips into New Year’s Day market closure as traders eye Friday data
Previous Story

Walmart stock today: WMT slips into New Year’s Day market closure as traders eye Friday data

POET Technologies stock ends 2025 lower as markets close for New Year’s Day — what investors watch next
Next Story

POET Technologies stock ends 2025 lower as markets close for New Year’s Day — what investors watch next

Go toTop